Clinical Trials Directory

Trials / Unknown

UnknownNCT05241938

PSLT Compared to Prostaglandin Analogue Eye Drops

Computer-guided Selective Laser Trabeculoplasty (PSLT) in the Treatment of Ocular Hypertension and Open-angle Glaucoma Compared to Prostaglandin Analogue Eye Drops: a Non-inferiority Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Federal University of Rio Grande do Sul · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Accepted

Summary

This study aims to compare the efficacy of PSLT and the topical use of prostaglandin-like hypotensive eye drops in the treatment of ocular hypertensive or glaucomatous patients in decreasing intraocular pressure and measuring changes in functional, structural and biomechanical parameters evaluated by computerized perimetry and optical coherence tomography (OCT) related to pressure change resulting from treatments

Detailed description

Patients with a diagnosis of ocular hypertension or bilateral glaucoma, naive or on treatment with up to two classes of hypotensive eye drops will be invited to participate in the study. These patients will have both eyes included in the study. A randomization will be made to allocate one eye to receive treatment with PSLT (treatment group), while the contralateral eye will receive treatment with prostaglandin eye drops (control). Patients will be followed up for 12 months and periodically tonometry, computerized perimetry, water overload test and OCT will be performed.

Conditions

Interventions

TypeNameDescription
PROCEDUREPSLTPSLT will be performed under topical anesthesia (proxymetacaine hydrochloride 5mg/ml eye drops) using a mirrored gonioscopy lens (Latina Ocular Instruments). A α2 agonist hypotensive eye drops (0.2% brimonidine tartrate) and 2% pilocarpine eye drops are applied 40 minutes before the procedure. After laser treatment, the patient will be instructed to use non-steroidal anti-inflammatory eye drops (thrice daily for 7 days).
DRUGProstaglandin analogue eye dropsProstaglandin analogue eye drops will be prescribed to be used continuously once a day in the fellow eye.

Timeline

Start date
2021-09-01
Primary completion
2022-12-20
Completion
2022-12-20
First posted
2022-02-16
Last updated
2022-02-16

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05241938. Inclusion in this directory is not an endorsement.